Viewing StudyNCT03511378



Ignite Creation Date: 2024-05-06 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 12:44 PM
Study NCT ID: NCT03511378
Status: COMPLETED
Last Update Posted: 2021-06-15
First Post: 2018-03-20

Brief Title: Immunogenicity Assessment of Peg-filgrastim vs Neulasta as Adjunct to Chemotherapy in Patients With Breast Cancer
Sponsor: Lupin Ltd
Organization: Lupin Ltd

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Immunogenicity View
Breast Carcinoma View
Breast neoplasms View
Breast Tumors View
Cancer of Breast View
Anti-Drug Antibodies ADA View